Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2016 - 2022)

Zimmer Biomet Holdings' Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $289.8 million for Q4 2022.

• In Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million; the TTM figure through Dec 2022 stood at $292.8 million (up 332.94% YoY), while the FY2022 annual figure was $292.8 million, up 1696.32% from the prior year.
• Asset Writedowns and Impairment was $289.8 million for Q4 2022 at Zimmer Biomet Holdings, up from $3.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $975.9 million in Q4 2018 to a low of -$142.0 million in Q4 2020.
• Historically, Asset Writedowns and Impairment has averaged $206.9 million across 5 years, with a median of $33.0 million in 2020.
• Biggest YoY gain for Asset Writedowns and Impairment was 258.79% in 2018; the steepest drop was 88.38% in 2018.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $975.9 million in 2018, then slumped by 92.82% to $70.1 million in 2019, then tumbled by 302.57% to -$142.0 million in 2020, then soared by 111.48% to $16.3 million in 2021, then surged by 1677.91% to $289.8 million in 2022.
• The last three Asset Writedowns and Impairment figures came in at $289.8 million (Q4 2022), $3.0 million (Q2 2022), and $16.3 million (Q2 2021), per Business Quant data.